Latest Regulatory Approval News

Diatreme Resources has submitted the Draft Environmental Impact Statement for its Northern Silica Project, marking a significant step toward regulatory approval and highlighting its potential to boost regional economies and support global solar energy growth.

Prescient Therapeutics has secured European authorization to initiate a Phase 2a clinical trial of its novel cancer drug PTX-100 for relapsed/refractory Cutaneous T-cell Lymphoma, enabling trial site activation in Italy.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Electro Optic Systems has inked a conditional US$80 million contract to supply a 100kW high energy laser weapon to a South Korean customer, marking its second major export order in this advanced defence technology.

Fortescue Ltd has announced a binding agreement to acquire the remaining 64% of Alta Copper, gaining full control of the Cañariaco Copper Project in Peru. The deal values Alta Copper at C$139 million and aligns with Fortescue’s expanding copper strategy.

Finder Energy has completed the acquisition of the Petrojarl I FPSO, gaining full control of vital infrastructure for the Kuda Tasi and Jahal project and setting the stage for a Final Investment Decision by mid-2026.

New Frontier Minerals is wrapping up its first reverse circulation drilling at Harts Range, with samples now en route for assay analysis. Meanwhile, progress at the Big One Deposit mining lease signals advancing copper ambitions.

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Vintage Energy has signed a formal agreement to acquire Metgasco's 25% interest in the Southern Flank joint ventures for $5.9 million, advancing its strategic position in key gas assets.

GenusPlus Group, partnering with ACCIONA, has won a $1.6 billion contract to build Victoria’s Western Renewables Link, a major transmission project set to power up to one million homes with renewable energy.

Goodman Group has announced an estimated ordinary dividend of AUD 0.15 per security for the six months ending December 2025, with payment scheduled for February 2026. The dividend is unfranked, and final details will be confirmed in February.

The Australian Treasurer has approved Hanwha Corporation’s increase of its direct equity stake in Austal Limited from 9.9% to 19.9%, setting the stage for potential strategic partnerships as Austal rides a wave of record revenues and defence contracts.